Log In
BCIQ
Print this Print this
 

Parlodel, bromocriptine

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionDopamine receptor agonist
Molecular Target Dopamine receptor
Mechanism of ActionDopamine receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard Indication Endocrine (unspecified)
Indication DetailsTreat hyperprolactinemia
Regulatory Designation
PartnerChina Medical System Holdings Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/17/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today